FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
This Quarter Return
-1.06%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$146M
AUM Growth
+$146M
(-27%)
Cap. Flow
-$46.9M
Cap. Flow
% of AUM
-32.08%
Top 10 Holdings %
Top 10 Hldgs %
94.95%
Holding
19
New
–
Increased
4
Reduced
8
Closed
3
Top Buys
1 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$1.76M |
2 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$861K |
3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$456K |
4 |
NVET
Nexvet Biopharma plc Ordinary Shares
NVET
|
$57.3K |
Top Sells
1 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$16.9M |
2 |
RGLS
Regulus Therapeutics
RGLS
|
$14.1M |
3 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$5.76M |
4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$4.26M |
5 |
Larimar Therapeutics
LRMR
|
$3.97M |
Sector Composition
1 | Healthcare | 58.92% |